Related references
Note: Only part of the references are listed.Are medical comorbid conditions of bipolar disorder due to immune dysfunction?
J. D. Rosenblat et al.
ACTA PSYCHIATRICA SCANDINAVICA (2015)
Elevated levels of IL-6 and IL-18 in manic and hypomanic states in rapid cycling bipolar disorder patients
Klaus Munkholm et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
PIOGLITAZONE ADJUNCTIVE THERAPY FOR DEPRESSIVE EPISODE OF BIPOLAR DISORDER: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Atefeh Zeinoddini et al.
DEPRESSION AND ANXIETY (2015)
Taking the fuel out of the fire: Evidence for the use of anti-inflammatory agents in the treatment of bipolar disorders
Ziada Ayorech et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
A Double-Blind, Randomized Controlled Clinical Trial Comparing Eicosapentaenoic Acid Versus Docosahexaenoic Acid for Depression
David Mischoulon et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis
D. M. Taylor et al.
ACTA PSYCHIATRICA SCANDINAVICA (2014)
The Immunology of Bipolar Disorder
Izabela Guimaraes Barbosa et al.
NEUROIMMUNOMODULATION (2014)
Inflamed moods: A review of the interactions between inflammation and mood disorders
Joshua D. Rosenblat et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects A Systematic Review and Meta-analysis of Randomized Clinical Trials
Ole Kohler et al.
JAMA PSYCHIATRY (2014)
Cytokines in Bipolar Disorder: Paving the Way for Neuroprogression
Izabela Guimaraes Barbosa et al.
NEURAL PLASTICITY (2014)
A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania
Pedro Vieira da Silva Magalhaes et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2013)
Cytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies
Amirhossein Modabbernia et al.
BIOLOGICAL PSYCHIATRY (2013)
Aspirin for treatment of lithium-associated sexual dysfunction in men: randomized double-blind placebo-controlled study
Sepideh Saroukhani et al.
BIPOLAR DISORDERS (2013)
So depression is an inflammatory disease, but where does the inflammation come from?
Michael Berk et al.
BMC MEDICINE (2013)
Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness
Michael Berk et al.
BMC MEDICINE (2013)
Chemokines in bipolar disorder: Trait or state?
Izabela Guimaraes Barbosa et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2013)
Prevalence, chronicity, burden and borders of bipolar disorder
Andrea Fagiolini et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Cytokines in bipolar disorder: A systematic review and meta-analysis
Klaus Munkholm et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis
Klaus Munkholm et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
Charles L. Raison et al.
JAMA PSYCHIATRY (2013)
Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial
Michael Berk et al.
BMC MEDICINE (2012)
Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?
Robert K. McNamara et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2012)
Omega-3 for Bipolar Disorder: Meta-Analyses of Use in Mania and Bipolar Depression
Jerome Sarris et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Omega-3 Fatty Acid Treatment, With or Without Cytidine, Fails to Show Therapeutic Properties in Bipolar Disorder A Double-Blind, Randomized Add-on Clinical Trial
Beth L. Murphy et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis
M. H. Bloch et al.
MOLECULAR PSYCHIATRY (2012)
Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2x2 clinical trial
Jonathan Savitz et al.
BMJ OPEN (2012)
The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial
Michael Berk et al.
JOURNAL OF AFFECTIVE DISORDERS (2011)
N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial
P. V. Magalhaes et al.
JOURNAL OF AFFECTIVE DISORDERS (2011)
N-acetylcysteine for major depressive episodes in bipolar disorder
Pedro V. Magalhaes et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2011)
A Meta-Analysis of Cytokines in Major Depression
Yekta Dowlati et al.
BIOLOGICAL PSYCHIATRY (2010)
Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder
Pieter Stolk et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2010)
Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder
Elisa Brietzke et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder
Elisa Brietzke et al.
JOURNAL OF AFFECTIVE DISORDERS (2009)
Weight gain in bipolar disorder:: pharmacological treatment as a contributing factor
C. Torrent et al.
ACTA PSYCHIATRICA SCANDINAVICA (2008)
N-acetyl cysteine for depressive symptoms in bipolar disorder - A double-blind randomized placebo-controlled trial
Michael Berk et al.
BIOLOGICAL PSYCHIATRY (2008)
Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study
Fabiano G. Nery et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder
Sophia Frangou et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder
Paul E. Keck et al.
BIOLOGICAL PSYCHIATRY (2006)
Treatment-resistant bipolar disorder
M Gitlin
MOLECULAR PSYCHIATRY (2006)
Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study
S Frangou et al.
BRITISH JOURNAL OF PSYCHIATRY (2006)
Omega-3 fatty acids are more beneficial in the depressive phase than in the manic phase in patients with bipolar I disorder
CC Chiu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Bipolar disorder, obesity, and pharmacotherapy-associated weight gain
PE Keck et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Share Paper
